Luye Pharma Group (HKG:2186) reported a profit attributable to owners of 387.8 million yuan for the six months ended June 30, 159% higher from 150 million yuan in the previous year, according to an interim report filed with the Hong Kong Bourse on Sunday.
Earnings per share were 0.1031 yuan, compared with the earnings per share of 0.0406 yuan a year ago.
The pharmaceutical company's revenue was 3.07 billion yuan, compared with 2.90 billion yuan in the prior year.
The company's stock closed over 1% higher on Monday's closing.
Price (HKD): $3.35, Change: $+0.050, Percent Change: +1.52%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments